Loomis, Sayles & Company
ISRG icon

Loomis, Sayles & Company’s Intuitive Surgical ISRG Stock Holding History

Loomis, Sayles & Company’s Portfolio ISRG Stock Details ISRG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$784M Sell
1,699,693
-15,794
-0.9% -$7.99M 1.05% 22
2025
Q4 		$972M Sell
1,715,487
-39,741
-2% -$21.2M 1.17% 18
2025
Q3 		$785M Buy
1,755,228
+26,994
+2% +$13M 0.93% 21
2025
Q2 		$939M Buy
1,728,234
+27,361
+2% +$14.3M 1.18% 18
2025
Q1 		$842M Sell
1,700,873
-23,408
-1% -$12.9M 1.22% 20
2024
Q4 		$900M Sell
1,724,281
-59,042
-3% -$30.8M 1.14% 19
2024
Q3 		$876M Sell
1,783,323
-49,268
-3% -$22.9M 1.15% 21
2024
Q2 		$815M Buy
1,832,591
+18,529
+1% +$7.38M 1.12% 21
2024
Q1 		$724M Sell
1,814,062
-10,584
-0.6% -$4M 1.03% 23
2023
Q4 		$616M Sell
1,824,646
-22,827
-1% -$6.8M 0.94% 27
2023
Q3 		$540M Sell
1,847,473
-66,259
-3% -$20.7M 0.93% 27
2023
Q2 		$654M Sell
1,913,732
-54,031
-3% -$16.3M 1.05% 25
2023
Q1 		$503M Sell
1,967,763
-56,256
-3% -$13.9M 0.87% 31
2022
Q4 		$537M Sell
2,024,019
-163,169
-7% -$39.8M 1.08% 27
2022
Q3 		$410M Buy
2,187,188
+131,180
+6% +$28.2M 0.83% 32
2022
Q2 		$413M Sell
2,056,008
-230,079
-10% -$54M 0.77% 32
2022
Q1 		$690M Sell
2,286,087
-111,050
-5% -$32.4M 0.92% 31
2021
Q4 		$861M Sell
2,397,137
-135,808
-5% -$46.7M 1.04% 26
2021
Q3 		$839M Sell
2,532,945
-6,087
-0.2% -$2.04M 1.03% 27
2021
Q2 		$778M Sell
2,539,032
-112,104
-4% -$31.5M 0.94% 27
2021
Q1 		$653M Sell
2,651,136
-88,488
-3% -$22.3M 0.85% 30
2020
Q4 		$747M Sell
2,739,624
-189,228
-6% -$47M 0.99% 28
2020
Q3 		$693M Sell
2,928,852
-9,843
-0.3% -$2.21M 1.01% 29
2020
Q2 		$558M Buy
2,938,695
+2,270,106
+340% +$407M 0.9% 31
2020
Q1 		$110M Buy
+668,589
New +$122M 0.23% 54
2014
Q2 		– Sell
-366,372
Closed -$17.8M – 765
2014
Q1 		$17.8M Buy
366,372
+63,009
+21% +$2.97M 0.05% 392
2013
Q4 		$12.9M Buy
+303,363
New +$12.8M 0.04% 456

Other funds holding ISRG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company's ISRG Position: Q1 2026 in Review

Loomis, Sayles & Company reduced its Intuitive Surgical (ISRG) stake by 0.92% in Q1 2026, selling an estimated $7.99M and leaving 1,699,693 shares worth $784M. The position accounts for 1.05% of the portfolio, ranked #22.

Loomis, Sayles & Company first reported a position in ISRG in Q4 2013 and has held it in 27 quarters since. The position peaked at $972M in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Loomis, Sayles & Company held 1,699,693 shares of Intuitive Surgical worth $784M as of Q1 2026.
  • Loomis, Sayles & Company sold 15,794 Intuitive Surgical shares in Q1 2026, an estimated $7.99M.
  • Intuitive Surgical made up 1.05% of Loomis, Sayles & Company's portfolio in Q1 2026, its #22 holding.
  • Loomis, Sayles & Company first reported a position in Intuitive Surgical in Q4 2013 and has held it in 27 quarters since.
  • Loomis, Sayles & Company's Intuitive Surgical position peaked at $972M in Q4 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.